<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">PANCURONIUM BROMIDE</span><br/>(pan-kyoo-roe'nee-um)<br/><span class="topboxtradename">Pavulon<br/></span><b>Classifications:</b> <span class="classification">autonomic nervous system agent</span>; <span class="classification">skeletal muscle relaxant, depolarizing, nondepolarizing</span><br/><b>Prototype: </b>Tubocurarine<br/><b>Pregnancy Category: </b>C<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>1 mg/mL, 2 mg/mL injection</p>
<h1><a name="action">Actions</a></h1>
<p>Synthetic curariform nondepolarizing neuromuscular blocking agent. Similar to tubocurarine chloride, however reported to be
         approximately five times as potent as tubocurarine but produces little or no histamine release or ganglionic blockade and
         thus does not cause bronchospasm or hypotension.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Produces skeletal muscle relaxation or paralysis by competing with acetylcholine at cholinergic receptor sites on skeletal
         muscle endplate and thus blocks nerve impulse transmission. In high doses has direct blocking effect on acetylcholine receptors
         of heart and may increase heart rate, cardiac output, and arterial pressure.
      </p>
<h1><a name="uses">Uses</a></h1>
<p>Adjunct to anesthesia to induce skeletal muscle relaxation. Also to facilitate management of patients undergoing mechanical
         ventilation.
      </p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Hypersensitivity to the drug or bromides; tachycardia. Safety during pregnancy (category C) or lactation is not established.</p>
<h1><a name="precaution">Cautious Use</a></h1>
<p>Debilitated patients; myasthenia gravis; pulmonary, liver or kidney disease; fluid or electrolyte imbalance.</p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Skeletal Muscle Relaxation</span><br/><span class="rdage">Adult/</span><span class="rdage">Child:</span> <span class="rdroute">IV</span> 0.040.1 mg/kg initial dose, may give additional doses of 0.01 mg/kg at 3060 min intervals<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1>
<table cellpadding="4" cellspacing="0" class="ivbox" width="100%">
<tr>
<td><span class="ivtitle">Intravenous</span><ul>
<li>Plastic syringe may be used for administration, but drug may adsorb to plastic with prolonged storage.</li>
<li>Use a test dose of 0.02 mg/kg in infants <img src="../images/special/greaterorequal.gif"/>1 mo.</li>
</ul>
<p><span class="routemethod">PREPARE:</span> <span class="methodtype">Direct:</span>  Give undiluted.  
               </p>
<p><span class="routemethod">ADMINISTER:</span> <span class="methodtype">Direct:</span> Give over 3090 sec.  
               </p>
<p><span class="routemethod">INCOMPATIBILITIES</span> <span class="incompattype">Y-site:</span>
<b>Diazepam,</b>
<b>thiopental.</b>
</p>
</td>
</tr>
</table>
<ul>
<li>Refrigerate at 2°8° C (36°46° F). Do not freeze.</li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">CV:</span>
<span class="speceff-common">Increased pulse rate and BP,</span> ventricular extrasystoles. <span class="typehead">Skin:</span> Transient acneiform rash, burning sensation along course of vein. <span class="typehead">Body as a Whole:</span> Salivation, skeletal muscle weakness, <span class="speceff-life">respiratory depression</span>. 
      <h1><a name="dtintefer">Diagnostic Test Interference</a></h1>
<p>Pancuronium may decrease <span class="alt">serum cholinesterase</span> concentrations.
      </p>
<h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span>
<span class="classification">general anesthetics</span> increase neuromuscular blocking and duration of action; <span class="classification">aminoglycosides</span>, <b>bacitracin,</b>
<b>polymyxin B,</b>
<b>clindamycin,</b>
<b>lidocaine</b>, parenteral <b>magnesium,</b>
<b>quinidine,</b>
<b>quinine,</b>
<b>trimethaphan,</b>
<b>verapamil</b> increase neuromuscular blockade; <span class="classification">diuretics</span> may increase or decrease neuromuscular blockade; <b>lithium</b> prolongs duration of neuromuscular blockade; <span class="classification">narcotic analgesics</span> possibly add to respiratory depression; <b>succinylcholine</b> increases onset and depth of neuromuscular blockade; <b>phenytoin</b> may cause resistance to or reversal of neuromuscular blockade. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Onset:</span> 3045 s. <span class="typehead">Peak:</span> 23 min. <span class="typehead">Duration:</span> 60 min. <span class="typehead">Distribution:</span> Well distributed to tissues and extracellular fluids; crosses placenta in small amounts. <span class="typehead">Metabolism:</span> Small amount metabolized in liver. <span class="typehead">Elimination:</span> Excreted primarily in urine. <span class="typehead">Half-Life:</span> 2 h. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Assess cardiovascular and respiratory status continuously.</li>
<li>Observe patient closely for residual muscle weakness and signs of respiratory distress during recovery period. Monitor BP
            and vital signs. Peripheral nerve stimulator may be used to assess the effects of pancuronium and to monitor restoration of
            neuromuscular function.
         </li>
<li>
            							Note: Consciousness is not affected by pancuronium. Patient will be awake and alert but unable to speak. 
            						
         </li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>